Managing Familial Hypercholesterolemia: Expert Guidelines for Patients and Doctors

Published: Aug 12, 2024

Familial hypercholesterolemia (FH) requires careful management to prevent heart disease. Learn about the latest expert guidelines for treating this genetic condition.
Contents

Early Diagnosis and Treatment

Guidelines emphasize the importance of early FH diagnosis and treatment. The National Lipid Association recommends universal cholesterol screening by age 11, with earlier testing for children with a family history of FH or early heart disease. Treatment often begins in childhood, typically between ages 8-10 for those with heterozygous FH. For adults, treatment should start immediately upon diagnosis.

LDL Cholesterol Targets

Lowering LDL cholesterol is the primary goal of FH treatment. For adults with FH, the European Atherosclerosis Society recommends an LDL target of <100 mg/dL for primary prevention, and <70 mg/dL for those with existing heart disease. Some experts suggest even lower targets of <55 mg/dL for very high-risk patients. Children's targets are typically set at <130 mg/dL.
Familial Hypercholesterolemia is a genetic condition characterized by high levels of cholesterol in the blood, increasing the risk of heart disease.

Stepwise Treatment Approach

Guidelines recommend a stepwise approach to treatment. High-intensity statin therapy is the first-line treatment for most patients. If LDL goals aren't met with statins alone, ezetimibe is typically added next. For patients still not at goal, PCSK9 inhibitors are recommended. LDL apheresis may be considered for severe cases, particularly those with homozygous FH.

Lifestyle and Additional Risk Factors

While medications are crucial, guidelines also stress the importance of lifestyle changes. These include a heart-healthy diet, regular exercise, weight management, and smoking cessation. Additionally, guidelines recommend aggressive management of other cardiovascular risk factors like high blood pressure and diabetes in FH patients.

Frequently Asked Questions

Guidelines suggest every 6-12 months for stable patients, more frequently when adjusting treatment.

Most guidelines support genetic testing, especially to help identify affected family members.

Guidelines recommend stopping statins before conception and using safer treatments during pregnancy.

Personalized Care is Key

While guidelines provide a framework, FH management should be tailored to each patient's unique needs and risks.
Ready to develop your personalized FH management plan? Consult with Doctronic to apply these guidelines to your specific case.

Related Articles

References

  1. Grundy SM, et al. Circulation. 2019;139(25):e1082-e1143.
  2. Mach F, et al. Eur Heart J. 2020;41(1):111-188.
  3. Gidding SS, et al. Circulation. 2015;132(22):2167-2192.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely